ADMA Biologics, Inc. (ADMA)
9.72
-0.21
(-2.11%)
USD |
NASDAQ |
Oct 02, 16:00
9.72
0.00 (0.00%)
After-Hours: 20:00
ADMA Biologics Market Cap : 2.190B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 2.190B |
| October 01, 2026 | 2.238B |
| September 30, 2026 | 2.260B |
| September 29, 2026 | 2.245B |
| September 28, 2026 | 2.281B |
| September 25, 2026 | 2.114B |
| September 24, 2026 | 2.145B |
| September 23, 2026 | 2.186B |
| September 22, 2026 | 2.211B |
| September 21, 2026 | 2.142B |
| September 18, 2026 | 2.053B |
| September 17, 2026 | 2.017B |
| September 16, 2026 | 2.006B |
| September 15, 2026 | 1.940B |
| September 14, 2026 | 2.060B |
| September 11, 2026 | 2.080B |
| September 10, 2026 | 2.116B |
| September 09, 2026 | 2.130B |
| September 08, 2026 | 2.150B |
| September 04, 2026 | 2.168B |
| September 03, 2026 | 2.159B |
| September 02, 2026 | 2.143B |
| September 01, 2026 | 2.103B |
| August 31, 2026 | 2.116B |
| August 28, 2026 | 2.105B |
| Date | Value |
|---|---|
| August 27, 2026 | 2.136B |
| August 26, 2026 | 2.170B |
| August 25, 2026 | 2.190B |
| August 24, 2026 | 2.152B |
| August 21, 2026 | 2.217B |
| August 20, 2026 | 2.199B |
| August 19, 2026 | 2.265B |
| August 18, 2026 | 2.150B |
| August 17, 2026 | 2.105B |
| August 14, 2026 | 2.134B |
| August 13, 2026 | 2.121B |
| August 12, 2026 | 2.204B |
| August 11, 2026 | 2.232B |
| August 10, 2026 | 2.197B |
| August 07, 2026 | 2.231B |
| August 06, 2026 | 2.267B |
| August 05, 2026 | 2.087B |
| August 04, 2026 | 2.008B |
| August 03, 2026 | 1.970B |
| July 31, 2026 | 1.965B |
| July 30, 2026 | 2.014B |
| July 29, 2026 | 2.023B |
| July 28, 2026 | 2.042B |
| July 27, 2026 | 1.970B |
| July 24, 2026 | 1.921B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vericel Corp. | 2.055B |
| BioMarin Pharmaceutical, Inc. | 11.07B |
| Emergent BioSolutions, Inc. | 324.73M |
| Exelixis, Inc. | 14.53B |
| Akebia Therapeutics, Inc. | 235.06M |
Market Cap Related Metrics
| PE Ratio | 13.80 |
| PS Ratio | 4.548 |
| Price to Book Value | 5.366 |
| Price to Free Cash Flow | 20.05 |
| Price | 9.72 |
| Earnings Yield | 7.25% |
| Operating PE Ratio | 10.76 |
| Normalized PE Ratio | 13.68 |